KLRS Kalaris Therapeutics, Inc. - Common Stock
$4,10
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 11, 2026
Rango 52S
$2–$12
19% of range
Calificación del Analista
STRONG BUY
14 analysts
Precio Objetivo
$19
+356% upside
P/E (TTM)
-1.4
ROE
-65.8%
Margen de Beneficio Neto
—
KLRS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.10
Capitalización Bursátil
$94M
P/E (TTM)
-1.4
BPA (TTM)
$-2.85
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-65.8%
Deuda/Capital
—
Rango 52S
$2 – $12
KLRS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
2019-12-31
→
2019-12-31
BPA
$-2.85
2021-12-31
→
2025-12-31
Flujo de caja libre
$-39M
2020-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
KLRS
Mediana de Pares
P/E (TTM)
-1.4
2.6
P/B (P/C)
1.2
3.1
Price / FCF (Precio / FCF)
-2.4
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
KLRS
Mediana de Pares
ROA
-67.9%
-60.9%
ROE
-65.8%
-99.5%
ROIC
-58.6%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
KLRS
Mediana de Pares
Current Ratio (Ratio corriente)
12.2
2.6
Quick Ratio (Ratio Rápido)
12.1
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
KLRS
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
KLRS
Mediana de Pares
KLRS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
14 analistas
- Compra fuerte 6 42,9%
- Compra 6 42,9%
- Mantener 2 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
7 analistas · 2026-08-19
Mediana
$20.00
← Por Debajo de Todos los Objetivos
$4.10
Mín
$7.00
Máx
$25.00
Objetivo mediano
$20.00
+387,8%
Objetivo medio
$18.71
+356,4%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.06%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.46 | $-0.53 | 0.07% |
| 31 de diciembre de 2025 | $-0.51 | $-0.54 | 0.03% |
| 30 de septiembre de 2025 | $-0.64 | $-0.67 | 0.03% |
| 30 de junio de 2025 | $-0.61 | $-0.53 | -0.08% |
| 31 de marzo de 2025 | $-2.52 | $-0.79 | -1.7% |
| 30 de junio de 2024 | $-1.15 | $-2.46 | 1.3% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| KLRS | $193M | -3.0 | — | — | -65.8% | — |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | — |
| FBIO | — | — | — | — | — | — |
| ALDX | $312M | -9.2 | — | — | -68.0% | — |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | — |
| ACRV | $76M | -1.2 | — | — | -61.0% | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $165.0K | |
| R&D Expense | $31M | $45M | $133M | $119M | $121M | $50M | $16M | |
| SG&A Expense | $15M | $7M | $48M | $52M | $49M | $22M | $11M | |
| Operating Expenses | $46M | $52M | $200M | $171M | $170M | $71M | $27M | |
| Operating Income | $-46M | $-52M | $-200M | $-171M | $-170M | $-71M | $-27M | |
| Interest Expense | $1M | $3M | · | · | · | · | · | |
| Interest Income | · | $5M | $6M | $2M | $1M | $1M | $2M | |
| Other Non-op | $3M | $188.0K | $4M | $351.0K | $-2M | $195.0K | $797.0K | |
| Pretax Income | $-43M | $-69M | $-191M | $-169M | $-171M | $-70M | $-24M | |
| Income Tax | $0 | $0 | $-126.0K | $-265.0K | $1M | · | · | |
| Net Income | $-43M | $-69M | $-190M | $-169M | $-172M | $-70M | $-24M | |
| EPS (Basic) | $-2.85 | $-51.77 | $-42.09 | $-2.20 | $-2.74 | · | · | |
| EPS (Diluted) | $-2.85 | $-51.77 | $-42.09 | $-2.20 | $-2.74 | · | · | |
| Shares (Basic) | 15,267,817 | 1,335,925 | 4,524,226 | 76,654,856 | 62,782,126 | · | · | |
| Shares (Diluted) | 15,267,817 | 1,335,925 | 4,524,226 | 76,654,856 | 62,782,126 | · | · | |
| EBITDA | $-46M | $-65M | $-200M | $-170M | · | $-71M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $98M | $2M | $90M | $106M | $202M | $123M | $61M | |
| Short-term Investments | $20M | $0 | $94M | $128M | $46M | $234M | $65M | |
| Prepaid Expense | $827.0K | $967.0K | $3M | $7M | $5M | $5M | $676.0K | |
| Current Assets | $119M | $3M | $188M | $243M | $253M | $361M | $127M | |
| PP&E (Net) | · | · | · | $930.0K | $2M | $812.0K | $350.0K | |
| PP&E (Gross) | · | · | $2M | $2M | $2M | $904.0K | $369.0K | |
| Accum. Depreciation | · | · | · | $1M | $281.0K | $92.0K | $19.0K | |
| Other Non-current Assets | $953.0K | $410.0K | $122.0K | $612.0K | $1M | · | · | |
| Total Assets | $122M | $6M | $191M | $277M | $287M | $371M | $139M | |
| Accounts Payable | $1M | $2M | $7M | $3M | $8M | $963.0K | $630.0K | |
| Accrued Liabilities | · | $5M | $10M | $14M | $20M | $8M | $5M | |
| Current Liabilities | $10M | $25M | $28M | $24M | $38M | $12M | $9M | |
| Capital Leases | $1M | $0 | $17M | $28M | $23M | $5M | $9M | |
| Total Liabilities | $43M | $57M | $45M | $53M | $61M | $18M | $18M | |
| Common Stock | $2.0K | $0 | $0 | $9.0K | $7.0K | $7.0K | · | |
| Paid-in Capital | $239M | $20M | $802M | $691M | $522M | $478M | $4M | |
| Retained Earnings | $-160M | $-117M | $-656M | $-466M | $-297M | $-125M | $-55M | |
| AOCI | $6.0K | $0 | $-62.0K | $-468.0K | $-155.0K | $-112.0K | $68.0K | |
| Stockholders' Equity | $79M | $-97M | $-45M | $225M | $225M | $353M | $-52M | |
| Liabilities + Equity | $122M | $6M | $191M | $277M | $287M | $371M | $139M | |
| Shares Outstanding | 22,902,418 | 1,356,431 | 4,962,997 | 93,093,243 | 63,565,886 | 61,931,255 | 2,099,740 |
Flujo de Efectivo 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $398.0K | $723.0K | $189.0K | $73.0K | $19.0K | |
| Stock-based Comp | $2M | $895.0K | $41M | $41M | $44M | $9M | $3M | |
| Deferred Tax | $0 | $0 | · | · | · | · | · | |
| Restructuring | · | $10M | · | · | · | · | · | |
| Other Non-cash | · | · | $25M | $-15M | · | $-529.0K | · | |
| Operating Cash Flow | $-38M | $-21M | $-124M | $-142M | $-106M | $-61M | $-20M | |
| CapEx | $200.0K | · | · | · | $26.0K | $235.0K | $339.0K | |
| Investing Cash Flow | $-20M | $95M | $38M | $-80M | $186M | $-169M | $-65M | |
| Stock Issued | $42M | · | · | $126M | · | · | · | |
| Net Stock Activity | $42M | · | · | $126M | · | · | · | |
| Financing Cash Flow | $155M | $19M | $70M | $127M | $232.0K | $292M | $121M | |
| Net Change in Cash | $97M | $-2M | $-16M | $-96M | $80M | $62M | $36M | |
| Taxes Paid | $0 | $0 | $220.0K | $613.0K | · | · | · | |
| Free Cash Flow | $-39M | · | · | · | · | $-61M | · | |
| Levered FCF | $-40M | · | · | · | · | · | · |
Rentabilidad 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -67.9% | -38.0% | -81.4% | -59.9% | · | -27.4% | · | |
| ROE | -65.8% | -491.2% | -111.6% | -70.6% | · | -19.2% | · | |
| ROIC | -58.6% | -57.8% | -137.0% | -76.1% | · | · | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.2 | 22.6 | 6.6 | 10.0 | · | 29.4 | · | |
| Quick Ratio | 12.1 | 22.6 | 6.5 | 9.6 | · | 29.0 | · | |
| Interest Coverage | -32.0 | · | · | · | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-43M | $-69M | $-190M | $-169M | $-172M | $-70M | · | |
| Market Cap | $193M | $49M | $1.79B | $10.98B | · | $54.75B | · | |
| P/E | -3.0 | -0.2 | -0.4 | -53.6 | -108.6 | · | · | |
| P/B | 2.5 | 0.4 | 12.2 | 48.9 | · | 155.1 | · | |
| P / Tangible Book | 2.5 | · | · | 48.9 | 84.0 | 155.1 | · | |
| P / Cash Flow | -5.0 | -0.7 | -14.3 | -77.3 | · | -900.4 | · | |
| P / FCF | -5.0 | · | · | · | · | -896.9 | · | |
| Earnings Yield | -33.8% | -535.9% | -269.1% | -1.9% | -0.92% | · | · |
Estado de resultados 15
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $9M | $8M | $7M | $9M | $8M | $6M | $4M | $36M | $3M | $2M | $33M | $34M | $35M | $31M | $28M | $30M | |
| SG&A Expense | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $976.0K | $602.0K | $10M | $13M | $12M | $13M | $12M | $13M | |
| Operating Expenses | $12M | $12M | $11M | $13M | $12M | $10M | $7M | $38M | $4M | $3M | $62M | $47M | $47M | $43M | $40M | $43M | |
| Operating Income | $-12M | $-12M | $-11M | $-13M | $-12M | $-10M | $-7M | $-38M | $-4M | $-3M | $-62M | $-47M | $-47M | $-43M | $-40M | $-43M | |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1M | $1M | $815.0K | $499.0K | $78.0K | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $898.0K | $668.0K | |
| Other Non-op | $871.0K | $977.0K | $803.0K | $847.0K | $906.0K | $193.0K | $64.0K | $31.0K | $66.0K | $27.0K | $1M | $1M | $521.0K | $723.0K | $986.0K | $210.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-60M | $-44M | $-45M | · | $-39M | $-42M | |
| Income Tax | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-126.0K | $0 | $0 | $0 | $-415.0K | $0 | |
| Net Income | $-12M | $-11M | $-10M | $-12M | $-11M | $-10M | $-22M | $-38M | $-6M | $-3M | $-60M | $-44M | $-45M | $-41M | $-38M | $-42M | |
| EPS (Basic) | $-0.48 | $-0.46 | $0.92 | $-0.64 | $-0.61 | $-2.52 | $-16.75 | $-28.16 | $-4.26 | $-2.60 | $-40.78 | $-0.39 | $-0.48 | $-0.44 | $-0.32 | $-0.50 | |
| EPS (Diluted) | $-0.48 | $-0.46 | $0.92 | $-0.64 | $-0.61 | $-2.52 | $-16.75 | $-28.16 | $-4.26 | $-2.60 | $-40.78 | $-0.39 | $-0.48 | $-0.44 | $-0.32 | $-0.50 | |
| Shares (Basic) | 23,797,306 | 23,723,618 | -26,188,317 | 18,701,708 | 18,701,286 | 4,053,140 | -2,654,598 | 1,352,265 | 1,325,706 | 1,312,552 | -297,299,471 | 113,894,188 | 94,625,837 | 93,303,672 | -136,754,517 | 84,948,837 | |
| Shares (Diluted) | 23,797,306 | 23,723,618 | -26,188,317 | 18,701,708 | 18,701,286 | 4,053,140 | -2,654,598 | 1,352,265 | 1,325,706 | 1,312,552 | -297,299,471 | 113,894,188 | 94,625,837 | 93,303,672 | -136,754,517 | 84,948,837 | |
| EBITDA | $-12M | $-12M | · | $-13M | $-12M | $-10M | · | $-6M | $-8M | $-32M | · | $-47M | $-47M | $-43M | · | $-43M |
Balance general 20
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $34M | $98M | $42M | $88M | $101M | $2M | $117M | $105M | $86M | $90M | $96M | $197M | $116M | $106M | $124M | |
| Short-term Investments | $50M | $63M | $20M | $35M | · | · | $0 | $5M | $25M | $54M | $94M | $118M | $50M | $87M | $128M | $140M | |
| Prepaid Expense | $2M | $861.0K | $827.0K | $1M | $3M | $1M | $967.0K | $626.0K | $230.0K | $771.0K | $3M | $6M | $5M | $7M | $7M | $6M | |
| Current Assets | $96M | $98M | $119M | $78M | $92M | $102M | $3M | $123M | $130M | $141M | $188M | $220M | $253M | $212M | $243M | $272M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $673.0K | $759.0K | $844.0K | $930.0K | $943.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Other Non-current Assets | $2M | $2M | $953.0K | $976.0K | $691.0K | $410.0K | $410.0K | · | · | · | $122.0K | $1M | $684.0K | $490.0K | $612.0K | $734.0K | |
| Total Assets | $100M | $110M | $122M | $81M | $93M | $103M | $6M | $123M | $131M | $144M | $191M | $248M | $283M | $244M | $277M | $294M | |
| Accounts Payable | $1M | $905.0K | $1M | $494.0K | $4M | $2M | $2M | $51.0K | $110.0K | $765.0K | $7M | $4M | $5M | $4M | $3M | $5M | |
| Accrued Liabilities | · | · | · | · | · | · | · | $1M | $2M | $5M | $10M | $16M | $17M | $12M | $14M | $14M | |
| Current Liabilities | $9M | $8M | $10M | $6M | $8M | $7M | $25M | $1M | $2M | $8M | $28M | $33M | $31M | $25M | $24M | $21M | |
| Capital Leases | $1M | $1M | $1M | $1M | · | · | $0 | · | $8M | $16M | $17M | $20M | $23M | $26M | $28M | $20M | |
| Total Liabilities | $42M | $41M | $43M | $39M | $40M | $39M | $57M | $1M | $11M | $24M | $45M | $53M | $54M | $51M | $53M | $40M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $0 | $11.0K | $11.0K | $11.0K | $0 | $11.0K | $11.0K | $9.0K | $9.0K | $9.0K | |
| Paid-in Capital | $240M | $239M | $239M | $192M | $191M | $191M | $20M | $818M | $813M | $807M | $802M | $792M | $782M | $701M | $691M | $681M | |
| Retained Earnings | $-182M | $-171M | $-160M | $-150M | $-138M | $-127M | $-117M | $-697M | $-693M | $-686M | $-656M | $-596M | $-552M | $-507M | $-466M | $-428M | |
| AOCI | $-73.0K | $-49.0K | $6.0K | $6.0K | · | · | $0 | $-134.0K | $-139.0K | $-138.0K | $-62.0K | $-200.0K | $-225.0K | $-301.0K | $-468.0K | $-563.0K | |
| Stockholders' Equity | $58M | $69M | $79M | $42M | $53M | $64M | $-97M | $121M | $120M | $120M | $146M | $195M | $229M | $194M | $225M | $253M | |
| Liabilities + Equity | $100M | $110M | $122M | $81M | $93M | $103M | $6M | $123M | $131M | $144M | $191M | $248M | $283M | $244M | $277M | $294M | |
| Shares Outstanding | 23,804,981 | 22,992,291 | 22,902,418 | 18,702,418 | 18,702,418 | 18,702,418 | 1,356,431 | 115,438,119 | 115,312,411 | 114,881,765 | 4,962,997 | 113,966,594 | 113,716,018 | 93,427,990 | 93,093,243 | 92,640,109 |
Flujo de Efectivo 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | $141.0K | $86.0K | $85.0K | $86.0K | $86.0K | $85.0K | |
| Stock-based Comp | $644.0K | $580.0K | $333.0K | $638.0K | $591.0K | $374.0K | $280.0K | $-10M | $-5M | $31.0K | $10M | $10M | $10M | $10M | $9M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| Restructuring | · | · | · | · | · | · | · | $100.0K | $500.0K | $10M | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-11M | $-12M | $-7M | $-11M | $-13M | $-7M | $-8M | $43M | $36M | $-5M | $-31M | $-34M | $-27M | $-32M | $-32M | $-35M | |
| CapEx | · | · | $17.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $20M | $-50M | $15M | · | · | · | · | $20M | $30M | $40M | $25M | $-67M | $38M | $42M | $14M | $-39M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Financing Cash Flow | $-377.0K | $-2M | $48M | $0 | $0 | $107M | $8M | $12M | $5M | $7M | $11.0K | $0 | · | · | $292.0K | $126M | |
| Net Change in Cash | $9M | $-64M | $56M | $-46M | $-13M | $100M | $-274.0K | $-16M | $7M | $2M | $-6M | $-101M | $81M | $10M | $-18M | $53M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | $-131.0K | $1.0K | · | · | $-390.0K | $0 |
Rentabilidad 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.0% | -10.2% | · | -11.7% | -10.1% | -8.2% | · | -2.2% | -2.9% | -15.6% | · | -16.3% | -18.8% | -17.3% | · | -13.8% | |
| ROE | -20.8% | -16.4% | · | -14.6% | -13.1% | -11.1% | · | -2.6% | -3.5% | -19.3% | · | -19.7% | -23.4% | -21.4% | · | -16.2% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | -24.0% | -20.6% | · | · | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.0 | 12.2 | · | 12.9 | 12.0 | 14.3 | · | 86.8 | 55.1 | 18.5 | · | 6.7 | 8.3 | 8.5 | · | 13.1 | |
| Quick Ratio | 10.7 | 12.0 | · | 12.7 | 11.6 | 14.1 | · | 86.3 | 54.9 | 18.4 | · | 6.5 | 8.1 | 8.1 | · | 12.7 | |
| Interest Coverage | · | · | · | · | · | -7.2 | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-46M | $-44M | · | $-72M | $-65M | $-57M | · | $-91M | $-99M | $-134M | · | $-173M | $-173M | $-172M | · | $-176M | |
| Market Cap | $97M | $133M | · | $108M | $50M | $150M | · | $2.15B | $1.92B | $1.99B | · | $5.64B | $8.89B | $8.47B | · | $16.81B | |
| P/E | -1.9 | -1.4 | · | -0.2 | -0.1 | -0.2 | · | -0.5 | -2.2 | -4.4 | · | -27.3 | -37.1 | -39.1 | · | -69.8 | |
| P/B | 1.7 | 1.9 | · | 2.6 | 0.9 | 2.4 | · | 17.7 | 15.9 | 16.6 | · | 28.9 | 38.8 | 43.7 | · | 66.4 | |
| P / Tangible Book | 1.7 | 1.9 | · | 2.6 | 0.9 | 2.4 | · | 17.7 | 15.9 | 16.6 | · | 28.9 | 38.8 | 43.7 | · | 66.4 | |
| P / Cash Flow | · | -11.5 | · | · | · | -20.2 | · | · | · | -45.0 | · | · | · | -263.6 | · | · | |
| Earnings Yield | -53.8% | -73.3% | · | -552.4% | -1331.5% | -467.5% | · | -190.3% | -46.5% | -22.5% | · | -3.7% | -2.7% | -2.6% | · | -1.4% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Beneficio neto | $-43M | $-69M | $-190M | $-169M | $-172M |
| EPS Diluido | $-2.85 | $-51.77 | $-42.09 | $-2.20 | $-2.74 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 12.2 | 22.6 | 6.6 | 10.0 | — |
| Ratio Rápido | 12.1 | 22.6 | 6.5 | 9.6 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-39M | — | — | — | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 58 declarantes · $74.1M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 13 (-2 vs trimestre anterior) | 11 (+4 vs trimestre anterior) | 15 (0 vs trimestre anterior) | 9 (+1 vs trimestre anterior) | -626K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | $52 426 382 | 12 881 175 | 70,79% | Acciones |
| RTW INVESTMENTS, LP | $5 291 000 | 1 300 000 | 7,14% | Acciones |
| Alyeska Investment Group, L.P. | $2 330 836 | 572 687 | 3,15% | Acciones |
| VANGUARD GROUP INC | $2 155 137 | 255 348 | 2,91% | Acciones |
| Siren, L.L.C. | $1 773 698 | 435 798 | 2,40% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 622 758 | 398 712 | 2,19% | Acciones |
| Ikarian Capital, LLC | $1 465 201 | 360 000 | 1,98% | Acciones |
| UBS Group AG | $1 066 873 | 262 131 | 1,44% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $607 859 | 149 351 | 0,82% | Acciones |
| Woodline Partners LP | $407 000 | 100 000 | 0,55% | Acciones |
| ADAR1 Capital Management, LLC | $407 000 | 100 000 | 0,55% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $404 332 | 99 306 | 0,55% | Acciones |
| WHI TRUST Co LLC | $396 797 | 97 493 | 0,54% | Acciones |
| CITADEL ADVISORS LLC | $389 792 | 95 772 | 0,53% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $375 502 | 92 261 | 0,51% | Acciones |
| Verdad Advisers, LP | $326 809 | 80 297 | 0,44% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $269 349 | 66 179 | 0,36% | Acciones |
| Fortis Capital Advisors, LLC | $162 800 | 40 000 | 0,22% | Acciones |
| Belpointe Asset Management LLC | $162 800 | 40 000 | 0,22% | Acciones |
| Pale Fire Capital SE | $161 278 | 39 626 | 0,22% | Acciones |
| Squarepoint Ops LLC | $157 814 | 38 775 | 0,21% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $132 275 | 32 500 | 0,18% | Acciones |
| Stonepine Capital Management, LLC | $122 597 | 30 122 | 0,17% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $122 128 | 30 007 | 0,16% | Acciones |
| Trexquant Investment LP | $121 030 | 29 737 | 0,16% | Acciones |
| STATE STREET CORP | $107 896 | 26 510 | 0,15% | Acciones |
| NORTHERN TRUST CORP | $105 165 | 25 839 | 0,14% | Acciones |
| Velan Capital Investment Management LP | $101 750 | 25 000 | 0,14% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $97 057 | 23 847 | 0,13% | Acciones |
| WealthTrust Asset Management, LLC | $83 093 | 20 416 | 0,11% | Acciones |
| Independent Advisor Alliance | $73 769 | 18 125 | 0,10% | Acciones |
| RBF Capital, LLC | $70 781 | 17 391 | 0,10% | Acciones |
| MORGAN STANLEY | $69 642 | 17 111 | 0,09% | Acciones |
| Quadrature Capital Ltd | $67 265 | 16 527 | 0,09% | Acciones |
| GOLDMAN SACHS GROUP INC | $65 340 | 16 054 | 0,09% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $57 879 | 14 221 | 0,08% | Acciones |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $50 875 | 12 500 | 0,07% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $48 168 | 11 835 | 0,07% | Acciones |
| MARSHALL WACE, LLP | $42 068 | 10 336 | 0,06% | Acciones |
| Sigma Planning Corp | $41 380 | 10 167 | 0,06% | Acciones |
| FMR LLC | $31 770 | 7 806 | 0,04% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $28 490 | 7 000 | 0,04% | Acciones |
| Integrated Wealth Concepts LLC | $20 350 | 5 000 | 0,03% | Acciones |
| Tower Research Capital LLC (TRC) | $10 419 | 2 560 | 0,01% | Acciones |
| Steward Partners Investment Advisory, LLC | $9 015 | 2 215 | 0,01% | Acciones |
| BlackRock, Inc. | $7 021 | 1 725 | 0,01% | Acciones |
| Vanguard Global Advisers, LLC | $2 951 | 725 | 0,00% | Acciones |
| BARCLAYS PLC | $1 233 | 303 | 0,00% | Acciones |
| Strengthening Families & Communities, LLC | $1 091 | 268 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $212 | 52 | 0,00% | Acciones |
| Parallel Advisors, LLC | $199 | 49 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $194 | 46 | 0,00% | Acciones |
| HRT FINANCIAL LP | $55 | 13 723 | 0,00% | Acciones |
| HARBOUR INVESTMENTS, INC. | $53 | 13 | 0,00% | Acciones |
| Virtu Financial LLC | $44 | 10 845 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $28 | 7 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $20 | 5 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $0 | 12 | 0,00% | Acciones |
Informantes de la empresa 30 insiders · 13 directivos · 20 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Andrew Oxtoby | President and Chief Executive Officer | 19 de marzo de 2026 A | — | 0 | 0 | $0 |
| Vikas Sinha | Officer Title: President, Chief Financial Officer and Chief Executive Officer | 21 de febrero de 2025 S | 49 129 | 0 | 0 | $0 |
| Diana Brainard | Chief Executive Officer | 19 de noviembre de 2024 S | 723 363 | 0 | 0 | $0 |
| Liisa Ann Bayko | Chief Financial Officer | 20 de julio de 2026 A | — | 0 | 0 | $0 |
| Matthew Gall | Chief Financial Officer | 19 de marzo de 2026 A | — | 0 | 0 | $0 |
| Matthew Feinsod | Chief Medical Officer | 19 de marzo de 2026 A | 4 030 | 0 | 0 | $0 |
| Brett R Hagen | Chief Accounting Officer | 19 de marzo de 2026 A | 0 | 0 | 1 | $-12 869 |
| Edward Miller | General Counsel | 21 de febrero de 2025 S | 6 517 | 0 | 0 | $0 |
| Cintia Piccina | Chief Commercial Officer | 3 de julio de 2023 A | 147 000 | 0 | 0 | $0 |
| Ann M. Leen | Chief Scientific Officer | 2 de febrero de 2023 A | 124 006 | 0 | 0 | $0 |
| Jeroen B Van Beek | Chief Commercial Officer | 16 de noviembre de 2022 S | 333 726 | 0 | 0 | $0 |
| Ercem Atillasoy | This Form 4/A is being filed correct the transaction dates reported in the original Form 4 filed on October 24, 2022. Officer T | 21 de octubre de 2022 S | 131 372 | 0 | 0 | $0 |
| Agustin Melian | Chief Medical Officer | 4 de octubre de 2021 S | 453 529 | 0 | 0 | $0 |
| Laurie Keating | Consejero | 1 de agosto de 2026 A | — | 0 | 0 | $0 |
| Napoleone Ferrara | Consejero | 3 de junio de 2026 A | 504 000 | 0 | 0 | $0 |
| Michael Dybbs | Consejero | 3 de junio de 2026 A | — | 0 | 0 | $0 |
| Morana Jovan-Embiricos | Consejero | 3 de junio de 2026 A | 100 197 | 0 | 0 | $0 |
| David Hallal | Consejero | 3 de junio de 2026 A | 2 143 662 | 0 | 0 | $0 |
| Anthony P Adamis | Consejero | 3 de junio de 2026 A | — | 0 | 0 | $0 |
| Srinivas Akkaraju | Consejero | 3 de junio de 2026 A | 11 444 503 | 0 | 0 | $0 |
| Leone D Patterson | Consejero | 3 de junio de 2026 A | — | 0 | 0 | $0 |
| Samir Chandrakant Patel | Consejero | 10 de abril de 2025 A | 100 800 | 0 | 0 | $0 |
| Derek N. Adams | Consejero | 6 de junio de 2024 A | 70 000 | 0 | 0 | $0 |
| Malcolm Brenner | Consejero | 6 de junio de 2024 A | 100 197 | 0 | 0 | $0 |
| Juan Vera | Consejero | 6 de junio de 2024 A | 2 409 928 | 0 | 0 | $0 |
| Shawn Tomasello | Consejero | 6 de junio de 2024 A | 70 000 | 0 | 0 | $0 |
| Jeffrey S Bornstein | Consejero | 6 de junio de 2024 A | 110 197 | 0 | 0 | $0 |
| ElevateBio, LLC | Consejero | 28 de julio de 2022 A | 16 674 766 | 0 | 0 | $0 |
| ANSBERT GADICKE | Consejero | 28 de julio de 2022 A | 16 674 766 | 0 | 0 | $0 |
| John Robert Wilson | Consejero | 25 de mayo de 2021 A | 3 164 954 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×4 presentaciones | 22 de mayo de 2026 | 54,20% | Enmienda | — | SEC |
| ElevateBio, LLC (2) | 5 de agosto de 2022 | — | Presentación inicial | — | SEC |
| F2 MG Ltd. (2), F2-TPO Investments, LLC (2), F2 MC, LLC (2), F2 Capital I 2020 LLC (2), F2 Bioscience AV 2022 LLC (2), Globeways Holdings Ltd. (2), Globeways Holdings II Ltd. (2), Morana Jovan-Embiricos (2) | 5 de agosto de 2022 | — | Presentación inicial | — | SEC |
| ElevateBio LLC (2) | 13 de agosto de 2020 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.